GGrantIndex
← Leaderboards

Kathrin Banach

Loyola University Chicago

$7,857,301
Attributed
$10,711,828
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY200725
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,711,828 · 5

By mechanism

R01$10,711,828 · 5

Top collaborators

Most similar at Loyola University Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Signal Transduction

Research focus

Signal TransductionHeart AtriumCardiacTissuesMuscle CellsCouplingGenerationsAction PotentialsItpr1 GeneMediatingArrhythmiaIn VivoIon ChannelCellsVoltagePhysiologicalHeartRegulationPropertyVentricularAtrial FibrillationEventPredispositionLink

Grant awards (23)

Atrial Excitation-Contraction Coupling, Calcium Signaling and Electro-Mechanical Alternans$706,810
R01 · FY2025 · HL · contact PI
IP3 receptor, NOX2 and calcium signaling domains in atrial physiology and pathophysiology$673,508
R01 · FY2025 · HL · contact PI
Atrial Excitation-Contraction Coupling, Calcium Signaling and Electro-Mechanical Alternans$692,674
R01 · FY2024 · HL · contact PI
IP3 receptor, NOX2 and calcium signaling domains in atrial physiology and pathophysiology$660,039
R01 · FY2024 · HL · contact PI
Atrial Excitation-Contraction Coupling, Calcium Signaling and Electro-Mechanical Alternans$706,810
R01 · FY2023 · HL
IP3 receptor, NOX2 and calcium signaling domains in atrial physiology and pathophysiology$673,508
R01 · FY2023 · HL
Atrial Excitation-Contraction Coupling, Calcium Signaling and Electro-Mechanical Alternans$706,810
R01 · FY2022 · HL
IP3 receptor, NOX2 and calcium signaling domains in atrial physiology and pathophysiology$672,443
R01 · FY2022 · HL
Pathophysiological Regulation of Atrial Alternans and Atrial Fibrillation$387,500
R01 · FY2020 · HL
The Role of p21-activated Kinase (Pak1) in Atrial Fibrillation$412,231
R01 · FY2019 · HL · contact PI
Pathophysiological Regulation of Atrial Alternans and Atrial Fibrillation$387,500
R01 · FY2019 · HL
The Role of p21-activated Kinase (Pak1) in Atrial Fibrillation$411,024
R01 · FY2018 · HL · contact PI
Pathophysiological Regulation of Atrial Alternans and Atrial Fibrillation$387,500
R01 · FY2018 · HL
The Role of p21-activated Kinase (Pak1) in Atrial Fibrillation$411,024
R01 · FY2017 · HL · contact PI
Pathophysiological Regulation of Atrial Alternans and Atrial Fibrillation$387,500
R01 · FY2017 · HL
The Role of p21-activated Kinase (Pak1) in Atrial Fibrillation$467,054
R01 · FY2016 · HL · contact PI
Embryonic Stem Cell Derived Biological Pacemaker for the Heart$353,250
R01 · FY2011 · HL · contact PI
Embryonic Stem Cell Derived Biological Pacemaker for the Heart$353,250
R01 · FY2010 · HL · contact PI
Embryonic Stem Cell Derived Biological Pacemaker for the Heart$353,250
R01 · FY2009 · HL · contact PI
Embryonic Stem Cell Derived Biological Pacemaker for the Heart$234,929
R01 · FY2009 · HL · contact PI
Embryonic Stem Cell Derived Biological Pacemaker for the Heart$314,000
R01 · FY2008 · HL · contact PI
Embryonic Stem Cell Derived Biological Pacemaker for the Heart$340,710
R01 · FY2007 · HL · contact PI
Embryonic Stem Cell Derived Biological Pacemaker for the Heart$18,504
R01 · FY2007 · HL · contact PI